GSK plc Announces Share Buyback Transaction on 17 October 2025

GSK plc, acting through BNP Paribas SA, purchased 414,000 of its ordinary shares on 17 October 2025 as part of its existing buyback programme. The shares were bought at prices ranging from 1,597.50p to 1,620.50p per share, with a volume-weighted average price of 1,608.93p. The purchased shares will be held as Treasury shares. Following this transaction, GSK plc will hold 252,108,344 ordinary shares in treasury and have 4,063,308,575 ordinary shares in issue (excluding Treasury shares). The total number of voting rights in the company is 4,063,308,575, with 6.20% of voting rights attributable to the ordinary shares held in treasury. This buyback is part of the non-discretionary agreement with BNP Paribas SA announced on 30 September 2025. Since then, the company has purchased a total of 4,643,500 ordinary shares.